Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Cisapride Monohydrate

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,926Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 Johnson & Johnson Innovative Medicine
    U.S.A
    		 Janssen Pharmaceutical Ltd County Cork IE R1-CEP 1997-061 - Rev 02 Cisapride monohydrate 2008-06-20 Withdrawn by Holder Chemical 2010-04-01 995
    28/10/2024 Johnson & Johnson Innovative Medicine
    U.S.A
    		 JANSSEN PHARMACEUTICA NV Beerse BE R1-CEP 1996-100 - Rev 02 Cisapride monohydrate 2007-03-07 Withdrawn by Holder Chemical 2010-04-01 995